Market Cap : 5.89 B | Enterprise Value : 4.84 B | PE Ratio : | PB Ratio : 6.96 |
---|
NAS:IONS has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
NAS:IONS has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
This valuation method assumes that the stock valuation will revert to its historical (10-Year) mean in terms of PS Ratio. The reason we use PS Ratio instead of PE Ratio or PB Ratio is because PS Ratio is independent of profit margin, and can be applied to a broader range of situations.
Median PS Value is calculated as trailing twelve months (TTM) Revenue per Share times 10-Year median PS Ratio. Ionis Pharmaceuticals's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2020 was $5.221. Ionis Pharmaceuticals's 10-Year median PS Ratio is 12.6911. Therefore, the Median PS Value for today is $66.26.
As of today (2021-04-15), Ionis Pharmaceuticals's share price is $41.830000. Ionis Pharmaceuticals's Median PS Value is $66.26. Therefore, Ionis Pharmaceuticals's Price to Median PS Value for today is 0.63.
During the past 13 years, the highest Price to Median PS Value of Ionis Pharmaceuticals was 6.32. The lowest was 0.41. And the median was 0.95.
* All numbers are in millions except for per share data and ratio. All numbers are indicated in the company's associated stock exchange currency.
* The bar in red indicates where Ionis Pharmaceuticals's Median PS Value falls into.
Ionis Pharmaceuticals's Median PS Value for today is calculated as
Median PS Value | = | Revenue per Share (TTM) | * | 10-Year Median PS Ratio |
= | 5.221 | * | 12.6911 | |
= | 66.26 |
10-Year Median PS Ratio is 12.6911.
Ionis Pharmaceuticals's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2020 was 0.957 (Mar. 2020 ) + 1.044 (Jun. 2020 ) + 1.146 (Sep. 2020 ) + 2.074 (Dec. 2020 ) = $5.221.
* All numbers are in millions except for per share data and ratio. All numbers are indicated in the company's associated stock exchange currency.
This valuation method assumes that the stock valuation will revert to its historical (10-Year) mean in terms of PS Ratio. The reason we use PS Ratio instead of PE Ratio or PB Ratio is because PS Ratio is independent of profit margin, and can be applied to a broader range of situations.
It also assumes that over time the profit margin is constant. If a company increases its profit margin to a sustainable level, this value might under-estimate its value. If it has permanent declined profit margins, this may over-estimate the company's value.
Ionis Pharmaceuticals's Price to Median PS Value for today is calculated as
Price to Median PS Value | = | Share Price | / | Median PS Value |
= | 41.830000 | / | 66.26 | |
= | 0.63 |
* All numbers are in millions except for per share data and ratio. All numbers are indicated in the company's associated stock exchange currency.
No Headline